These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29412832)

  • 1. Alpha cell dysfunction in type 1 diabetes.
    Yosten GLC
    Peptides; 2018 Feb; 100():54-60. PubMed ID: 29412832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiology of glucagon.
    Taborsky GJ
    J Diabetes Sci Technol; 2010 Nov; 4(6):1338-44. PubMed ID: 21129328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pax4 transdifferentiates glucagon-secreting alpha cells to insulin-secreting beta endocrine pancreatic cells].
    Collombat P; Mansouri A
    Med Sci (Paris); 2009; 25(8-9):763-5. PubMed ID: 19765395
    [No Abstract]   [Full Text] [Related]  

  • 4. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.
    Spijker HS; Song H; Ellenbroek JH; Roefs MM; Engelse MA; Bos E; Koster AJ; Rabelink TJ; Hansen BC; Clark A; Carlotti F; de Koning EJ
    Diabetes; 2015 Aug; 64(8):2928-38. PubMed ID: 25918235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror.
    Martínez MS; Manzano A; Olivar LC; Nava M; Salazar J; D'Marco L; Ortiz R; Chacín M; Guerrero-Wyss M; Cabrera de Bravo M; Cano C; Bermúdez V; Angarita L
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
    Cryer PE
    Endocrinology; 2012 Mar; 153(3):1039-48. PubMed ID: 22166985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive change of intra-islet GLP-1 production during diabetes development.
    O'Malley TJ; Fava GE; Zhang Y; Fonseca VA; Wu H
    Diabetes Metab Res Rev; 2014 Nov; 30(8):661-8. PubMed ID: 24510483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes.
    Gilon P
    J Mol Biol; 2020 Mar; 432(5):1367-1394. PubMed ID: 31954131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule glucagon release inhibitors with activity in human islets.
    Kalwat MA; Rodrigues-Dos-Santos K; Binns DD; Wei S; Zhou A; Evans MR; Posner BA; Roth MG; Cobb MH
    Front Endocrinol (Lausanne); 2023; 14():1114799. PubMed ID: 37152965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
    Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
    J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia.
    Asadi F; Dhanvantari S
    Front Endocrinol (Lausanne); 2021; 12():726368. PubMed ID: 34659118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells.
    Kim MJ; Choi OK; Chae KS; Lee H; Chung SS; Ham DS; Kim JW; Yoon KH; Park KS; Jung HS
    Islets; 2015; 7(5):e1129096. PubMed ID: 26744903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta- and alpha-cell dysfunction in type 2 diabetes.
    Del Prato S; Marchetti P
    Horm Metab Res; 2004; 36(11-12):775-81. PubMed ID: 15655708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA as a Signaling Hub Controlling Glucagon Secretion From Pancreatic α-Cells.
    Ng XW; Chung YH; Asadi F; Kong C; Ustione A; Piston DW
    Diabetes; 2022 Nov; 71(11):2384-2394. PubMed ID: 35904939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible contribution of taurine to distorted glucagon secretion in intra-islet insulin deficiency: a metabolome analysis using a novel α-cell model of insulin-deficient diabetes.
    Bessho M; Murase-Mishiba Y; Imagawa A; Terasaki J; Hanafusa T
    PLoS One; 2014; 9(11):e113254. PubMed ID: 25393115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Autonomous Dysfunction and Insulin Resistance in Pancreatic α Cells.
    Honzawa N; Fujimoto K; Kitamura T
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis.
    Wendt A; Eliasson L
    Curr Opin Pharmacol; 2022 Apr; 63():102199. PubMed ID: 35245797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic network control of glucagon secretion and counterregulation.
    Farhy LS; McCall AL
    Methods Enzymol; 2009; 467():547-581. PubMed ID: 19897107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic α-cells - The unsung heroes in islet function.
    Wendt A; Eliasson L
    Semin Cell Dev Biol; 2020 Jul; 103():41-50. PubMed ID: 31983511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.